- Home
- PLUR vs XBP Comparison
PLUR vs XBP Comparison
Compare PLUR & XBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUR
- XBP
- Stock Information
- Founded
- PLUR 2001
- XBP 2020
- Country
- PLUR Israel
- XBP United States
- Employees
- PLUR N/A
- XBP N/A
- Industry
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- XBP Business Services
- Sector
- PLUR Health Care
- XBP Consumer Discretionary
- Exchange
- PLUR Nasdaq
- XBP Nasdaq
- Market Cap
- PLUR 36.9M
- XBP 67.2M
- IPO Year
- PLUR N/A
- XBP N/A
- Fundamental
- Price
- PLUR $3.40
- XBP $0.61
- Analyst Decision
- PLUR Strong Buy
- XBP
- Analyst Count
- PLUR 1
- XBP 0
- Target Price
- PLUR $12.00
- XBP N/A
- AVG Volume (30 Days)
- PLUR 8.2K
- XBP 883.0K
- Earning Date
- PLUR 11-11-2025
- XBP 11-14-2025
- Dividend Yield
- PLUR N/A
- XBP N/A
- EPS Growth
- PLUR N/A
- XBP N/A
- EPS
- PLUR N/A
- XBP N/A
- Revenue
- PLUR $1,336,000.00
- XBP $148,332,000.00
- Revenue This Year
- PLUR $97.38
- XBP N/A
- Revenue Next Year
- PLUR $293.97
- XBP N/A
- P/E Ratio
- PLUR N/A
- XBP N/A
- Revenue Growth
- PLUR 309.82
- XBP 0.23
- 52 Week Low
- PLUR $3.33
- XBP $0.42
- 52 Week High
- PLUR $7.13
- XBP $2.56
- Technical
- Relative Strength Index (RSI)
- PLUR 31.92
- XBP 49.19
- Support Level
- PLUR $3.60
- XBP $0.50
- Resistance Level
- PLUR $4.00
- XBP $0.68
- Average True Range (ATR)
- PLUR 0.18
- XBP 0.06
- MACD
- PLUR -0.04
- XBP 0.02
- Stochastic Oscillator
- PLUR 0.00
- XBP 69.13
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
About XBP XBP Europe Holdings Inc.
XBP Global Holdings Inc is a multinational leader in business process automation, serving over 2,500 clients-including more than 30 Fortune 100 companies. Its proprietary software and deep domain expertise position it as a trusted technology and services partner. With cloud-based solutions and a global footprint, XBP Global delivers measurable value, improves advances digital transformation, improves market-wide liquidity by expediting payments, and promotes sustainable business practices.